• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

SugarBud Announces Closing of the Disposition of its Oil and Gas Assets and Becomes a Pure-Play Canadian Cannabis Company

Share:

April 8, 2019

SugarBud Craft Growers Corp. is pleased to announce that it has closed the sale of the Company’s oil and gas assets with several arm’s length purchasers pursuant to which the Purchasers have acquired all of the Company’s oil and gas assets for gross proceeds of approximately $1.75 million in cash.

The series of Dispositions eliminates approximately $4.1 million of asset retirement obligations associated with the assets and significantly strengthens the Company’s balance sheet. SugarBud has no debt or abandonment liabilities and does not anticipate requiring any additional financing prior to receipt of its Cultivation License from Health Canada.

Date: April 08, 2019

Source: Cision

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Topical Pain Relief Market with (Covid-19) Impact AnalysisTopical Pain Relief Market with (Covid-19) Impact Analysis
  • New Medical-Grade UV Device Can Kill COVID Virus in 2 SecondsNew Medical-Grade UV Device Can Kill COVID Virus in 2 Seconds
  • iOnctura Raises EUR 15 Million in Series a Financing to Progress Its Pipeline Into Clinical DevelopmentiOnctura Raises EUR 15 Million in Series a Financing to Progress Its Pipeline Into Clinical Development
  • Global Pharmaceutical Contract Manufacturing and Contract Market By 2026: Challenges, Drivers, Growth Opportunities, Segmentation, Insights and Overall Outlook & Analysis from 2020.Global Pharmaceutical Contract Manufacturing and Contract Market By 2026: Challenges, Drivers, Growth Opportunities, Segmentation, Insights and Overall Outlook & Analysis from 2020.
  • Kyocera to Purchase Major Assets of U.S.-based Renovis Surgical Technologies, Inc.Kyocera to Purchase Major Assets of U.S.-based Renovis Surgical Technologies, Inc.
  • Aytu BioScience and Neos Therapeutics Announce Definitive Merger Agreement, Creating a Combined $100M Revenue(1) Specialty Pharmaceutical CompanyAytu BioScience and Neos Therapeutics Announce Definitive Merger Agreement, Creating a Combined $100M Revenue(1) Specialty Pharmaceutical Company
  • Celularity and GX Acquisition Corp. Announce Merger Agreement to Create a Publicly Listed Leader in Allogeneic Cellular TherapyCelularity and GX Acquisition Corp. Announce Merger Agreement to Create a Publicly Listed Leader in Allogeneic Cellular Therapy
  • Highmark Members Embrace Lark’s AI-Driven Chronic Conditions CoachingHighmark Members Embrace Lark’s AI-Driven Chronic Conditions Coaching

Trending This Week

  • Bronchiolitis Drugs Market Expected to Witness High Growth Over the Forecast to 2027
  • Blood Bags Market Size Key Opportunity, Application and Forecast to 2027
  • Aesthetic Devices Market 2020 Industry Trends, Growth, Analysis, Opportunities and Overview
  • Pharmaceutical Packaging Market Size, Industry Demand, Regional Analysis & Insights 2027
  • Akerna Closes Acquisition of Viridian Sciences
  • Cryoport Acquires Temperature-Controlled Logistics Provider in Australia

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications